Unlock more results with a Fundz subscription — Get started today!

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Giiant Pharma Inc Announced The Closing Of Us$11M In Seed Financing To Develop Its Precision Delivery Technology Platform In Gastroenterology

05/21/21, 11:04 AM

Location

montreal

Round Type

seed

Giiant Pharma inc., a Montreal-based preclinical-stage biotech company, today announced the closing of US$11M (CAD$ 13.5M) million in Seed financing. The round was co-led by Amplitude Ventures and Genesys Capital, with participation from Fonds de solidarité FTQ, AmorChem II Fund, Theodorus Investment Funds, Anges Québec, and other angel investors.

Company Info

Company

Giiant Pharma Inc

Location

montreal, quebec, canada

Additional Info

Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.

Company news

Wed, 06 Sep 2023 07:00:00 GMT

Palisade Bio Transforms GI-Focused Pipeline Through Exclusive Worldwide Licensing Agreement with Giiant Pharma, Inc. for Multiple Oral Drug Candidates Targeting Inflammatory Bowel Disease - GlobeNewswire

Fri, 21 May 2021 07:00:00 GMT

Giiant Pharma Inc Announced the Closing of US$11m in Seed Financing to Develop Its Precision Delivery Technology Platform in Gastroenterology - Business Wire

Thu, 20 Feb 2025 08:00:00 GMT

Palisade Bio, Inc. Announces Receipt of Cash Proceeds from - GlobeNewswire

Tue, 19 Mar 2024 07:00:00 GMT

AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion - The Globe and Mail

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.